Intuitive Surgical, Inc. (ISRG) Debt to Assets Ratio: 0.01%
The debt to assets ratio for Intuitive Surgical, Inc. (ISRG) is 0.01% as of Tuesday, June 9, 2026.
ISRG Debt to Assets Ratio Metrics
DEBT TO ASSETS RATIO
0.01%
ISRG Competitors' Debt to Assets Ratio
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | — | 0.01% |
| Pfizer Inc. (PFE) | $146.48B | 0.32% |
| Gilead Sciences, Inc. (GILD) | $155.82B | 0.42% |
| Abbott Laboratories (ABT) | $158.94B | 0.17% |
| Danaher Corporation (DHR) | $133.37B | 0.22% |
| CVS Health Corporation (CVS) | $123.84B | 0.36% |
| Thermo Fisher Scientific Inc. (TMO) | $183.61B | 0.37% |
| Amgen Inc. (AMGN) | $185.96B | 0.60% |
| Bristol-Myers Squibb Company (BMY) | $115.34B | 0.52% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $113.14B | 0.15% |
Leverage Ratios Comparison
Debt/Assets
0.0%
Debt/Equity
0.02
Current Ratio
4.87
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
- Debt/Assets: Shows % of assets funded by creditors (bounded 0-100%)
- Debt/Equity: Shows debt relative to shareholder investment (can exceed 100%)
- Both measure leverage but from different perspectives
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Intuitive Surgical, Inc. Debt to Assets Ratio Formula & Definition
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Intuitive Surgical, Inc. Debt to Assets Ratio FAQ
- What is the debt to assets ratio for Intuitive Surgical, Inc. (ISRG)?
- The debt to assets ratio for ISRG stock is 0.01%.
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa